Radiopharmaceutical Indications Should Not Be Disease Specific - CORAR
This article was originally published in The Gray Sheet
Executive Summary
Disease specific radiopharmaceutical indications should not be required by FDA, Council on Radionuclides and Radiopharmaceuticals Secretary Robert Morgan (DuPont Merck) maintained at a Feb. 27 public meeting.